This new oral drug was tested on 380 people at various locations in Spain, England, Germany and US. Out of 208 patients, 191 were reported to be completely cured after 12 weeks. By 24 weeks, the success rate went well above 96%, according to the info here.
The cost of the new treatment, however, hasn’t been clarified as of yet. But it is expected to remain quite high, in which case, the drug may not be available to many of the patients in need of it.